ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Michigan Scientist David Beer Sought Retraction Of Potti’s NEJM Paper Over Misuse Of His Data

July 30, 2010

Pat Barr, Early NBCC Activist, Dead.

June 27, 2003

Columbia Next for comprehensive Center Review

February 18, 1977